pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pain · news · pharmadog
← back to Pain
News · Pain
217
stories
2d
EAK Distribution LLC Recalls HOME GROWN Green Sprouting Calabrese Broccoli Seeds, 8 oz, Heirloom Because of Possible Health Risk
fda recalls
3d
Foghorn cuts 40% of workforce
biospace
3d
How big is Pennsylvania’s measles outbreak?
stat
3d
Top journal’s special issue on women’s health casts spotlight on menopause and pain
stat
4d
STAT+: Invivyd’s pursuit of a Covid vaccine alternative gets a lift, but an FDA hurdle may await
stat
4d
Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
fda recalls
4d
U.S. poised to boot legal immigrants from Medicaid, including refugees and sex-trafficking victims
stat
5d
Rural MAHA followers say Trump hasn’t improved health of their communities, poll finds
stat
5d
Kratom and 7-OH should be regulated, experts agree. They’re split on how
stat
5d
Amgen reveals 6-point drop in lupus severity behind phase 2 win for Horizon antibody
fiercebiotech
6d
White House takes stock of US-based manufacturing for 86 essential drugs
endpoints
7d
FDA nod for Mirum’s Atebrioz makes 3 options for ultra-rare bone disease
biospace
12d
Amgen asset from $27.8B Horizon buy scores in Phase 3 Sjögren's study
biospace
12d
Amgen reports a Phase 3 win with Sjögren’s drug candidate
biopharma dive
13d
Opinion: The science on relieving cancer symptoms is clear. Why isn’t insurance paying?
stat
13d
Global Mix Inc. Recalls Niwali Tejocote Capsules and Niwali Tejocote Pieces Because of Possible Health Risk
fda recalls
14d
President Trump’s newest vaccine ‘demands’ repeat old misinformation
stat
14d
How J&J paved the way for Compass’ coming psychedelic drug launch
biopharma dive
14d
Novo struggles to appease restive investors with consumer plans, blockbuster ambitions
fiercebiotech
14d
Are healthcare systems really ready for GLP-1s?
biopharma dive
14d
Addiction clinics see rising cases of kratom and 7-OH withdrawal
stat
14d
Skeptical about modern medicine? I know the feeling — and want to listen
stat
17d
Artelo’s ex-AstraZeneca cannabinoid agonist holds its own against GLP-1 drug semaglutide in obese mice
fiercebiotech
17d
In Sudan, attacks on hospitals force patients to make dangerous journeys
stat
19d
Gias Foods, Inc. Recalls Bettergoods Authentic Italian Lemon Alfredo Fettuccine Because of Possible Health Risk
fda recalls
20d
STAT+: Medicare to expand its pilot that pays for technology to manage chronic diseases
stat
20d
STAT+: Medicare’s AI prior authorization pilot was rushed and full of problems, new documents reveal
stat
22d
Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels
fda medwatch
23d
This week in charts: RA’s insatiable appetite, Novartis’ big slide and a reverse merger spree
biopharma dive
24d
Karyopharm pushes off debt payment; Amgen eyes broader Imdelltra use
biopharma dive
← prev
page 1 of 8
next →
